REMEGEN (09995.HK) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Nov28

BlackRock cuts holdings in RemeGen by 185,500 shares

12:15

Nov26

East China Securities Issues Buy Rating for Rongchang Biotechnology

07:34

Nov18

CFC 上调荣昌生物目标价及盈利预测

01:17

Nov11

Rongchang Biotech Reports Strong Revenue Growth but Persistent Losses in Q3 2025

09:57

Nov5

荣昌生物 3Q25 Performance Slightly Better Than Expected, PD-1/VEGF Dual Antibody Development Strategy Revealed

03:02

Nov3

Rongchang Biotech Signs 400 Million RMB Wealth Management Product Agreement with SPDB Yantai Branch

09:18

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 679.82 M, Net Income -110.55 M, EPS -0.2001

Aug22

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 626.05 M, Net Income -213.9 M, EPS -0.4029

Apr28

Earning Release(CST)

FY2025 Q1 Earning Release (HKD) Revenue 563.3 M, Net Income -272.18 M, EPS -0.4926

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change